These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11980984)

  • 61. High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study.
    Torres HA; Kontoyiannis DP; Rolston KV
    Support Care Cancer; 2004 Jul; 12(7):511-6. PubMed ID: 14986077
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
    Petraitis V; Petraitiene R; Groll AH; Sein T; Schaufele RL; Lyman CA; Francesconi A; Bacher J; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2001 Feb; 45(2):471-9. PubMed ID: 11158743
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.
    Mokaddas EM; Al-Sweih NA; Khan ZU
    J Med Microbiol; 2007 Feb; 56(Pt 2):255-259. PubMed ID: 17244809
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
    Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
    Martínez M; López-Ribot JL; Kirkpatrick WR; Bachmann SP; Perea S; Ruesga MT; Patterson TF
    J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular identification and antifungal susceptibility testing of
    Kermani F; Sadeghian M; Shokohi T; Hashemi S; Moslemi D; Davodian S; Abastabar M; Bandalizadeh Z; Faeli L; Seifi Z; Fami Zaghrami M; Haghani I
    Curr Med Mycol; 2021 Mar; 7(1):44-50. PubMed ID: 34553097
    [TBL] [Abstract][Full Text] [Related]  

  • 67. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.
    Pfaller MA; Diekema DJ; Jones RN; Sader HS; Fluit AC; Hollis RJ; Messer SA;
    J Clin Microbiol; 2001 Sep; 39(9):3254-9. PubMed ID: 11526159
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Species distribution & antifungal susceptibility pattern of oropharyngeal Candida isolates from human immunodeficiency virus infected individuals.
    Das PP; Saikia L; Nath R; Phukan SK
    Indian J Med Res; 2016 Apr; 143(4):495-501. PubMed ID: 27377507
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Oesophageal candidiasis: clinical and mycological analysis].
    Olmos MA; Araya V; Concetti H; Ramallo J; Piskorz E; Pérez H; Cahn P; Kaufman S; Guelfand L
    Acta Gastroenterol Latinoam; 2005; 35(4):211-8. PubMed ID: 16496852
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunosuppression level in HIV-positive patients with oropharyngeal candidiasis.
    Arora U; Jagdev M; Jindal N
    Indian J Med Microbiol; 2009; 27(2):174-5. PubMed ID: 19384052
    [No Abstract]   [Full Text] [Related]  

  • 72. Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter.
    Wu CJ; Lee HC; Yang YL; Chang CM; Chen HT; Lin CC; Lee NY; Chu WL; Hsieh LY; Wang YL; Lauderale TL; Tseng FC; Ko NY; Ko WC; Lo HJ
    Clin Microbiol Infect; 2012 May; 18(5):485-90. PubMed ID: 21939471
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Parotitis due to Torulopsis glabrata.
    Pujol F; Angirekula M; Weiner M; Jindrak K; Pachter BR
    Clin Infect Dis; 1995 Nov; 21(5):1342-3. PubMed ID: 8589177
    [No Abstract]   [Full Text] [Related]  

  • 74. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Caspofungin in the treatment of oropharyngeal candidiasis.
    Garbino J; Lew D; Hirschel B; Rohner P
    Int J Clin Pract; 2003 Mar; 57(2):143-4. PubMed ID: 12661800
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Determinants for the development of oropharyngeal colonization or infection by fluconazole-resistant Candida strains in HIV-infected patients.
    Masiá Canuto M; Gutiérrez Rodero F; Ortiz de la Tabla Ducasse V; Hernández Aguado I; Martín González C; Sánchez Sevillano A; Martín Hidalgo A
    Eur J Clin Microbiol Infect Dis; 2000 Aug; 19(8):593-601. PubMed ID: 11014621
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002.
    Wang JL; Chang SC; Hsueh PR; Chen YC
    J Microbiol Immunol Infect; 2004 Aug; 37(4):236-41. PubMed ID: 15340652
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fluconazole susceptibility of Candida species in Singapore by disc diffusion test.
    Oon LL; Yeo MG
    Ann Acad Med Singap; 2002 Jul; 31(4):497-501. PubMed ID: 12161887
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
    Shokri H; Sharifzadeh A
    J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
    Drago M; Scaltrito MM; Morace G;
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):619-24. PubMed ID: 15258831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.